Beta Bionics Inc
NASDAQ:BBNX
Cash Flow Statement
Cash Flow Statement
Beta Bionics Inc
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
(55)
|
(83)
|
(100)
|
(78)
|
|
| Depreciation & Amortization |
1
|
1
|
2
|
0
|
|
| Stock-Based Compensation |
6
|
9
|
14
|
14
|
|
| Other Non-Cash Items |
17
|
32
|
37
|
32
|
|
| Change in Working Capital |
(12)
|
(19)
|
(20)
|
(11)
|
|
| Cash from Operating Activities |
(48)
N/A
|
(68)
-41%
|
(82)
-20%
|
(57)
+31%
|
|
| Investing Cash Flow | |||||
| Capital Expenditures |
(3)
|
(4)
|
(6)
|
(4)
|
|
| Other Items |
(0)
|
(179)
|
(171)
|
(189)
|
|
| Cash from Investing Activities |
(3)
N/A
|
(183)
-5 153%
|
(176)
+3%
|
(193)
-9%
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
60
|
271
|
271
|
274
|
|
| Other |
(4)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
56
N/A
|
267
+380%
|
267
+0%
|
271
+1%
|
|
| Change in Cash | |||||
| Net Change in Cash |
4
N/A
|
16
+311%
|
9
-46%
|
21
+147%
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
(52)
N/A
|
(72)
-39%
|
(87)
-21%
|
(61)
+31%
|
|